The Community Guide

- gsearch

Search Results

Narrow Results:

2024 4
2023 1
2022 2
2021 5
2018 1
2013 3

United States 1

Journal Article 16

1 - 16 of 16 Results

Refine Results

Refine Results:

Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs

CITE Title : Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs Personal Author(s) : Tebbens, Radboud J. Duintjer;Pallansch, Mark A.;Chumakov, Konstantin M.;Halsey, Neal A.;Hovi, Tapani;Minor, Philip D.;Modlin, John F.;Patriarca, Peter A.;Sutter, Roland W.;Wright, Peter F.;Wassilak, Steven G.F.;Cochi, Stephen L.;Kim, Jong-Hoon;Thompson, Kimberly M.; Published Date : 4 2013;4-2013; Source : Risk Anal. 33(4):606-646 URL : https://stacks.cdc.gov/view/cdc/103524 Tebbens, Radboud J. Duintjer et al. (2013). Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs. 33(4). Tebbens, Radboud J. Duintjer et al. "Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs" 33, no. 4 (2013) Tebbens, Radboud J. Duintjer et al. "Review and assessment of poliovirus immunity and transmission: Synthesis of knowledge gaps and identification of research needs" vol. 33, no. 4, 2013 Export RIS Citation Information.

:

Tebbens, Radboud J. Duintjer ;

Pallansch, Mark A.

4 2013 | Risk Anal. 33(4):606-646

:

With the intensifying global efforts to eradicate wild polioviruses, policymakers face complex decisions related to achieving eradication and managing...
Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs)

CITE Title : Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs) Personal Author(s) : Duintjer Tebbens, Radboud J.;Pallansch, Mark A.;Kim, Jong-Hoon;Burns, Cara C.;Kew, Olen M.;Oberste, M Steven;Diop, Ousmane;Wassilak, Steven G.F.;Cochi, Stephen L.;Thompson, Kimberly M.; Published Date : 4 2013;4-2013; Source : Risk Anal. 33(4):680-702 URL : https://stacks.cdc.gov/view/cdc/103148 Duintjer Tebbens, Radboud J. et al. (2013). Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs). 33(4). Duintjer Tebbens, Radboud J. et al. "Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs)" 33, no. 4 (2013) Duintjer Tebbens, Radboud J. et al. "Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine-Derived Polioviruses (cVDPVs)" vol. 33, no. 4, 2013 Export RIS Citation Information.

:

Duintjer Tebbens, Radboud J. ;

Pallansch, Mark A.

4 2013 | Risk Anal. 33(4):680-702

:

The live, attenuated oral poliovirus vaccine (OPV) provides a powerful tool for controlling and stopping the transmission of wild polioviruses (WPVs),...
Worst-case scenarios: Modeling uncontrolled type 2 polio transmission

CITE Title : Worst-case scenarios: Modeling uncontrolled type 2 polio transmission Personal Author(s) : Kalkowska, Dominika A.;Wiesen, Eric;Wassilak, Steven G. F.;Burns, Cara C.;Pallansch, Mark A.;Badizadegan, Kamran;Thompson, Kimberly M.; Published Date : 2 2024;2-2024; Source : Risk Anal. 44(2):379-389 URL : https://stacks.cdc.gov/view/cdc/138307 Kalkowska, Dominika A. et al. (2024). Worst-case scenarios: Modeling uncontrolled type 2 polio transmission. 44(2). Kalkowska, Dominika A. et al. "Worst-case scenarios: Modeling uncontrolled type 2 polio transmission" 44, no. 2 (2024) Kalkowska, Dominika A. et al. "Worst-case scenarios: Modeling uncontrolled type 2 polio transmission" vol. 44, no. 2, 2024 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Wiesen, Eric

2 2024 | Risk Anal. 44(2):379-389

:

In May 2016, the Global Polio Eradication Initiative (GPEI) coordinated the cessation of all use of type 2 oral poliovirus vaccine (OPV2), except for ...
Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences

CITE Title : Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences Personal Author(s) : Kalkowska, Dominika A.;Wassilak, Steven G. F.;Wiesen, Eric;Burns, Cara C.;Pallansch, Mark A.;Badizadegan, Kamran;Thompson, Kimberly M.; Published Date : 2 2024;2-2024; Source : Risk Anal. 44(2):366-378 URL : https://stacks.cdc.gov/view/cdc/138308 Kalkowska, Dominika A. et al. (2024). Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences. 44(2). Kalkowska, Dominika A. et al. "Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences" 44, no. 2 (2024) Kalkowska, Dominika A. et al. "Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences" vol. 44, no. 2, 2024 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Wassilak, Steven G. F.

2 2024 | Risk Anal. 44(2):366-378

:

Due to the very low, but nonzero, paralysis risks associated with the use of oral poliovirus vaccine (OPV), eradicating poliomyelitis requires ending ...
Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization

CITE Title : Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization Personal Author(s) : Thompson, Kimberly M.;Kalkowska, Dominika A.;Kidd, Sarah E.;Burns, Cara C.;Badizadegan, Kamran; Published Date : 2 06 2024;2-06-; Source : Vaccine. 42(4):819-827 URL : https://stacks.cdc.gov/view/cdc/151746 Thompson, Kimberly M. et al. (2024). Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization. 42(4). Thompson, Kimberly M. et al. "Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization" 42, no. 4 (2024) Thompson, Kimberly M. et al. "Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization" vol. 42, no. 4, 2024 Export RIS Citation Information.

:

Thompson, Kimberly M. ;

Kalkowska, Dominika A.

2 06 2024 | Vaccine. 42(4):819-827

:

Delays in achieving polio eradication have led to ongoing risks of poliovirus importations that may cause outbreaks in polio-free countries. Because o...
Health economic analysis of vaccine options for the polio eradication endgame: 2022–2036

CITE Title : Health economic analysis of vaccine options for the polio eradication endgame: 2022–2036 Personal Author(s) : Thompson, Kimberly M.;Kalkowska, Dominika A.;Badizadegan, Kamran; Published Date : 11 2022;11-2022; Source : Expert Rev Vaccines. 21(11):1667-1674 URL : https://stacks.cdc.gov/view/cdc/127456 Thompson, Kimberly M. et al. (2022). Health economic analysis of vaccine options for the polio eradication endgame: 2022–2036. 21(11). Thompson, Kimberly M. and Kalkowska, Dominika A. and Badizadegan, Kamran "Health economic analysis of vaccine options for the polio eradication endgame: 2022–2036" 21, no. 11 (2022) Thompson, Kimberly M. et al. "Health economic analysis of vaccine options for the polio eradication endgame: 2022–2036" vol. 21, no. 11, 2022 Export RIS Citation Information.

:

Thompson, Kimberly M. ;

Kalkowska, Dominika A.

11 2022 | Expert Rev Vaccines. 21(11):1667-1674

:

Background:Multiple vaccine options are available for polio prevention and risk management. Integrated global risk, economic, and poliovirus transmiss...
Modeling undetected poliovirus circulation following the 2022 outbreak in the United States

CITE Title : Modeling undetected poliovirus circulation following the 2022 outbreak in the United States Personal Author(s) : Kalkowska, Dominika A.;Badizadegan, Kamran;Routh, Janell A.;Burns, Cara C.;Rosenberg, Eli S.;Brenner, I. Ravi;Zucker, Jane R.;Langdon-Embry, Marisa;Thompson, Kimberly M.; Published Date : 2024;Jan-Dec 2024; Source : Expert Rev Vaccines. 23(1):186-195 URL : https://stacks.cdc.gov/view/cdc/159461 Kalkowska, Dominika A. et al. (2024). Modeling undetected poliovirus circulation following the 2022 outbreak in the United States. 23(1). Kalkowska, Dominika A. et al. "Modeling undetected poliovirus circulation following the 2022 outbreak in the United States" 23, no. 1 (2024) Kalkowska, Dominika A. et al. "Modeling undetected poliovirus circulation following the 2022 outbreak in the United States" vol. 23, no. 1, 2024 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Badizadegan, Kamran

2024 | Expert Rev Vaccines. 23(1):186-195

:

Background:New York State (NYS) reported a polio case (June 2022) and outbreak of imported type 2 circulating vaccine-derived poliovirus (cVDPV2) (las...
Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan

CITE Title : Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan Personal Author(s) : Kalkowska, Dominika A.;Badizadegan, Kamran;Thompson, Kimberly M.; Published Date : 4 2023;4-2023; Source : Risk Anal. 43(4):660-676 URL : https://stacks.cdc.gov/view/cdc/123031 Kalkowska, Dominika A. et al. (2023). Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan. 43(4). Kalkowska, Dominika A. and Badizadegan, Kamran and Thompson, Kimberly M. "Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan" 43, no. 4 (2023) Kalkowska, Dominika A. et al. "Modeling scenarios for ending poliovirus transmission in Pakistan and Afghanistan" vol. 43, no. 4, 2023 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Badizadegan, Kamran

4 2023 | Risk Anal. 43(4):660-676

:

Pakistan and Afghanistan pose risks for international transmission of polioviruses as the last global reservoir for wild poliovirus type 1 (WPV1) and ...
Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV

CITE Title : Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV Personal Author(s) : Kalkowska, Dominika A.;Thompson, Kimberly M.; Published Date : 2 2021;2-2021; Source : Risk Anal. 41(2):312-319 URL : https://stacks.cdc.gov/view/cdc/153687 Kalkowska, Dominika A. and Thompson, Kimberly M. (2021). Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV. 41(2). Kalkowska, Dominika A. and Thompson, Kimberly M. "Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV" 41, no. 2 (2021) Kalkowska, Dominika A. and Thompson, Kimberly M. "Expected implications of globally-coordinated cessation of serotype 3 oral poliovirus vaccine (OPV) before serotype 1 OPV" vol. 41, no. 2, 2021 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Thompson, Kimberly M.

2 2021 | Risk Anal. 41(2):312-319

:

Globally coordinated cessation of all three serotypes of oral poliovirus vaccine (OPV) represents a critical part of a successful polio endgame, which...
Updated characterization of outbreak response strategies for 2019–2029: Impacts of using a novel type 2 oral poliovirus vaccine strain

CITE Title : Updated characterization of outbreak response strategies for 2019–2029: Impacts of using a novel type 2 oral poliovirus vaccine strain Personal Author(s) : Kalkowska, Dominika A.;Pallansch, Mark A.;Wilkinson, Amanda;Bandyopadhyay, Ananda S.;Konopka-Anstadt, Jennifer L.;Burns, Cara C.;Oberste, M. Steven;Wassilak, Steven G. F.;Badizadegan, Kamran;Thompson, Kimberly M.; Published Date : 2 2021;2-2021; Source : Risk Anal. 41(2):329-348 URL : https://stacks.cdc.gov/view/cdc/103521 Kalkowska, Dominika A. et al. (2021). Updated characterization of outbreak response strategies for 2019–2029: Impacts of using a novel type 2 oral poliovirus vaccine strain. 41(2). Kalkowska, Dominika A. et al. "Updated characterization of outbreak response strategies for 2019–2029: Impacts of using a novel type 2 oral poliovirus vaccine strain" 41, no. 2 (2021) Kalkowska, Dominika A. et al. "Updated characterization of outbreak response strategies for 2019–2029: Impacts of using a novel type 2 oral poliovirus vaccine strain" vol. 41, no. 2, 2021 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Pallansch, Mark A.

2 2021 | Risk Anal. 41(2):329-348

:

Delays in achieving the global eradication of wild poliovirus transmission continue to postpone subsequent cessation of all oral poliovirus vaccine (O...
Modeling poliovirus transmission in Pakistan and Afghanistan to inform vaccination strategies in under-vaccinated subpopulations

CITE Title : Modeling poliovirus transmission in Pakistan and Afghanistan to inform vaccination strategies in under-vaccinated subpopulations Personal Author(s) : Duintjer Tebbens, Radboud J.;Pallansch, Mark A.;Cochi, Stephen L.;Ehrhardt, Derek;Farag, Noha;Hadler, Stephen;Hampton, Lee M.;Martinez, Maureen;Wassilak, Steve G.F;Thompson, Kimberly M.; Published Date : 8 2018;8-2018; Source : Risk Anal. 38(8):1701-1717 URL : https://stacks.cdc.gov/view/cdc/159615 Duintjer Tebbens, Radboud J. et al. (2018). Modeling poliovirus transmission in Pakistan and Afghanistan to inform vaccination strategies in under-vaccinated subpopulations. 38(8). Duintjer Tebbens, Radboud J. et al. "Modeling poliovirus transmission in Pakistan and Afghanistan to inform vaccination strategies in under-vaccinated subpopulations" 38, no. 8 (2018) Duintjer Tebbens, Radboud J. et al. "Modeling poliovirus transmission in Pakistan and Afghanistan to inform vaccination strategies in under-vaccinated subpopulations" vol. 38, no. 8, 2018 Export RIS Citation Information.

:

Duintjer Tebbens, Radboud J. ;

Pallansch, Mark A.

8 2018 | Risk Anal. 38(8):1701-1717

:

Due to security, access, and programmatic challenges in areas of Pakistan and Afghanistan, both countries continue to sustain indigenous wild poliovir...
Global transmission of live polioviruses: Updated dynamic modeling of the polio endgame

CITE Title : Global transmission of live polioviruses: Updated dynamic modeling of the polio endgame Personal Author(s) : Kalkowska, Dominika A.;Pallansch, Mark A.;F. Wassilak, Steven G.;Cochi, Stephen L.;Thompson, Kimberly M.; Published Date : 2 2021;2-2021; Source : Risk Anal. 41(2):248-265 URL : https://stacks.cdc.gov/view/cdc/100242 Kalkowska, Dominika A. et al. (2021). Global transmission of live polioviruses: Updated dynamic modeling of the polio endgame. 41(2). Kalkowska, Dominika A. et al. "Global transmission of live polioviruses: Updated dynamic modeling of the polio endgame" 41, no. 2 (2021) Kalkowska, Dominika A. et al. "Global transmission of live polioviruses: Updated dynamic modeling of the polio endgame" vol. 41, no. 2, 2021 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Pallansch, Mark A.

2 2021 | Risk Anal. 41(2):248-265

:

SOCIAL MEDIA SUMMARYRisk Analysis modeling shows Global Polio Eradication Initiative not on track to succeed
Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart

CITE Title : Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart Personal Author(s) : Kalkowska, Dominika A.;Pallansch, Mark A.;Cochi, Stephen L.;Kovacs, Stephanie D.;Wassilak, Steven G. F.;Thompson, Kimberly M.; Published Date : 2 2021;2-2021; Source : Risk Anal. 41(2):320-328 URL : https://stacks.cdc.gov/view/cdc/100696 Kalkowska, Dominika A. et al. (2021). Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart. 41(2). Kalkowska, Dominika A. et al. "Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart" 41, no. 2 (2021) Kalkowska, Dominika A. et al. "Updated characterization of post-OPV cessation risks: Lessons from 2019 serotype 2 outbreaks and implications for the probability of OPV restart" vol. 41, no. 2, 2021 Export RIS Citation Information.

:

Kalkowska, Dominika A. ;

Pallansch, Mark A.

2 2021 | Risk Anal. 41(2):320-328

:

After the globally coordinated cessation of any serotype of oral poliovirus vaccine (OPV), some risks remain from undetected, existing homotypic OPV-r...
Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States

CITE Title : Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States Personal Author(s) : Dankwa, Emmanuelle A.;Donnelly, Christl A.;Brouwer, Andrew F.;Zhao, Rui;Montgomery, Martha;Weng, Mark K.;Martin, Natasha K.; Published Date : 12 03 2021;12-03-; Source : Vaccine. 39(49):7182-7190 URL : https://stacks.cdc.gov/view/cdc/117712 Dankwa, Emmanuelle A. et al. (2021). Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States. 39(49). Dankwa, Emmanuelle A. et al. "Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States" 39, no. 49 (2021) Dankwa, Emmanuelle A. et al. "Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States" vol. 39, no. 49, 2021 Export RIS Citation Information.

:

Dankwa, Emmanuelle A. ;

Donnelly, Christl A.

12 03 2021 | Vaccine. 39(49):7182-7190

:

BackgroundBetween September 2017 and June 2019, an outbreak of hepatitis A virus (HAV) occurred in Louisville, Kentucky, resulting in 501 cases and 6 ...
Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine-Related Polioviruses

CITE Title : Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine-Related Polioviruses Personal Author(s) : Tebbens, Radboud J. Duintjer;Pallansch, Mark A.;Kalkowska, Dominika A.;Wassilak, Steven G. F.;Cochi, Stephen L.;Thompson, Kimberly M.; Published Date : 4-2013 Source : Risk Anal. 33(4):703-749 URL : https://stacks.cdc.gov/view/cdc/175286 Tebbens, Radboud J. Duintjer et al. (2022). Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine-Related Polioviruses. 33(4). Tebbens, Radboud J. Duintjer et al. "Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine-Related Polioviruses" 33, no. 4 (2022) Tebbens, Radboud J. Duintjer et al. "Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine-Related Polioviruses" vol. 33, no. 4, 2022 Export RIS Citation Information.

:

Tebbens, Radboud J. Duintjer ;

Pallansch, Mark A.

4-2013 | Risk Anal. 33(4):703-749

:

With national and global health policymakers facing numerous complex decisions related to achieving and maintaining polio eradication, we expanded our...
Expert Review on Poliovirus Immunity and Transmission

CITE Title : Expert Review on Poliovirus Immunity and Transmission Personal Author(s) : Tebbens, Radboud J. Duintjer;Pallansch, Mark A.;Chumakov, Konstantin M.;Halsey, Neal A.;Hovi, Tapani;Minor, Philip D.;Modlin, John F.;Patriarca, Peter A.;Sutter, Roland W.;Wright, Peter F.;Wassilak, Steven G.F.;Cochi, Stephen L.;Kim, Jong-Hoon;Thompson, Kimberly M.; Published Date : 4 2013 Source : Risk Anal. 33(4):544-605 URL : https://stacks.cdc.gov/view/cdc/103534 Tebbens, Radboud J. Duintjer et al. (2013). Expert Review on Poliovirus Immunity and Transmission. 33(4). Tebbens, Radboud J. Duintjer et al. "Expert Review on Poliovirus Immunity and Transmission" 33, no. 4 (2013) Tebbens, Radboud J. Duintjer et al. "Expert Review on Poliovirus Immunity and Transmission" vol. 33, no. 4, 2013 Export RIS Citation Information.

:

Tebbens, Radboud J. Duintjer ;

Pallansch, Mark A.

4 2013 | Risk Anal. 33(4):544-605

:

Successfully managing risks to achieve wild polioviruses (WPVs) eradication and address the complexities of oral poliovirus vaccine (OPV) cessation to...